New X-Ray Technology For Better Management Of Lung Diseases
Australia: Researchers at Monash University have developed radical non-invasive X-ray technology to help diagnose, treat and manage...
Noninvasive XV Technology May Lead to Faster CF Diagnosis and Better Treatment
A new non-invasive tool, called XV technology, allows professionals to visualize airflow in a living lungs and could help in the...
Synspira Therapeutics, CF Foundation Agree to Support Development of SNSP003 for Malabsorption Syndr
The Cystic Fibrosis Foundation has reached an agreement with Synspira Therapeutics to support the further development of SNSP003, an...
Researchers describe unique genetic identity of primordial lung progenitors Findings may lead to bet
(Boston)--For the first time, researchers describe the genetic program behind primordial lung progenitors--embryonic cells that give rise...
Study Describes Genetic Mechanisms Behind Embryonic Lung Cells
The researchers hope the findings could one day lead to cell replacement therapies for respiratory diseases, including chronic...
Chronic Pain, Depression, and Anxiety in the CF Community
We need to come to grips with a problem deeply affecting the cystic fibrosis community. It’s an issue that we don’t talk about much:...
Allergan Announces Agreement to Divest Zenpep, Exocrine Pancreatic Insufficiency Treatment
Allergan has entered into a definite agreement to sell Zenpep (pancrelipase), a therapy for exocrine pancreatic insufficiency due to...
Are intestinal organoids the key to developing personalized therapy for cystic fibrosis?
Intestinal organoids have been utilized to develop personalized therapy for cystic fibrosis patients. Cystic fibrosis (CF) is a rare...
New treatment kills off infection that can be deadly to cystic fibrosis patients
Credit: CC0 Public Domain A new treatment developed by researchers at Aston University and Birmingham Children's Hospital has been found...
Proteostasis On Track to Develop Organoids for Personalized Medicine Strategy for CF Patients with R
A project aimed at personalized medicine based on the use of organoids, or “mini-organs,” from cystic fibrosis (CF) patients with rare...
